GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rosetta Genomics ROSGQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Rosetta Genomics

Its shares trade under the ticker ROSGQ. It has been listed since 27 February 2007. In the fiscal year to 31 December 2016, it reported revenue of $9.2m and a net loss of $16.2m. At that date it held total assets of $12.0m and shareholders' equity of $4.4m.

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
27 Feb 2007
Employees
86

Leadership

Pay as last reported

  • Mr. Brian MarkisonIndependent Chairman of the Board
  • Mr. Ron KalfusChief Financial Officer$262,785
  • Ms. Sigal Russo-GuetaSenior Director Of Finance
  • Dr. Dganit BarChief Scientific Officer$186,595
  • Dr. Eti MeiriVice President - Research$149,631
  • Mr. Roy DavisDirector
  • Mr. Gerald DogonExternal Independent Director
  • Dr. Joshua RosensweigIndependent Director
  • Dr. David SidranskyIndependent Director
  • Ms. Tali Yaron-EldarExternal Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.